Concorde Asset Management’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,999
Closed -$206K 211
2021
Q1
$206K Buy
+7,999
New +$210K 0.12% 199

Other funds holding IBD

Concorde Asset Management's IBD Position: Q2 2021 in Review

Concorde Asset Management sold out of Inspire Corporate Bond ETF (IBD) in Q2 2021, closing a stake of 7,999 shares — an estimated $206K sold.

Concorde Asset Management first reported a position in IBD in Q1 2021 and held it in 1 quarter. The position peaked at $206K in Q1 2021. 39 funds tracked by Wall St. Rank hold IBD as of Q2 2021.

  • Concorde Asset Management reported no remaining Inspire Corporate Bond ETF position as of Q2 2021 after selling out during the quarter.
  • Concorde Asset Management sold 7,999 Inspire Corporate Bond ETF shares in Q2 2021, an estimated $206K.
  • Concorde Asset Management first reported a position in Inspire Corporate Bond ETF in Q1 2021 and held it in 1 quarter.
  • Concorde Asset Management's Inspire Corporate Bond ETF position peaked at $206K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2021.

Based on Concorde Asset Management's 13F filing for Q2 2021, filed 20 Jul 2021.